Variant NM_000492.4:c.489+3A>G


Variant details:
Name NM_000492.4:c.489+3A>G
Protein name NP_000483.3:p.(=)
Genomic name (hg19) chr7:g.117171171A>G    UCSC    
#Exon/intron intron 4
Legacy Name 621+3A>G
Class disease-causing
Subclass CFTR-RD-causing
WT sequence TGTTTAGTTTGATTTATAAGAAGGT A ATACTTCCTTGCACAGGCCCCATGG
Mutant sequence TGTTTAGTTTGATTTATAAGAAGGT G ATACTTCCTTGCACAGGCCCCATGG

Other databases:
dbSNP
rs377729736







Pathogenicity predictors:

Not found





No patient found in CFTR-NGS catalogue


5 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 5
Asymptomatic compound heterozygote 2
CF 1
CFTR-RD1
  • Other  1
Pending (NBS) 1




Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing

Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
Other 609heterozygoteCF-causing - Trans
Pending (NBS) 1077heterozygoteCF-causing - Trans
CF 1535heterozygoteCF-causing - Cis
CF-causing - Trans
Asymptomatic compound heterozygote 4742heterozygoteCF-causing - Trans
Asymptomatic compound heterozygote 4741heterozygoteCFTR-RD-causing - Trans


Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing



            CFTR variants are clustered into five groups:
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.



Go to CFTRare